# Ypsomed sells pen needle and BGM business to MTD Medical Technology and Devices

Ypsomed AG sold its pen needle and blood glucose monitoring business to MTD Medical Technology and Devices S.p.A. The divestment allows Ypsomed to focus on its mylife Loop insulin pump solution.

- Type: Acquisition
- Announced: 2024-04-05
- Status: completed
- Products: pen needles, blood glucose monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md) (target)
- [MTD Medical Technology and Devices](https://endata.com/companies/76653.md) (acquirer)

## Sources

- [8advisory.com](https://www.8advisory.com/en/2024/04/05/eight-advisory-advised-ypsomed-ag-on-the-sale-of-its-pen-needle-and-blood-glucose-monitoring-business-tomtd-medical-technology-and-devices/), 2024-04-05: "Ypsomed, a leading developer and manufacturer in the field of self-medication and diabetes care, has carved-out and sold its pen needle and blood glucose monitoring systems (BGMs) business to MTD."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.